Feasibility of three times weekly symptom screening in pediatric cancer patients

被引:3
|
作者
Calligan, Maryann [1 ]
Chakkalackal, Lauren [1 ]
Dadzie, Grace [1 ]
Tardif-Theriault, Cassandra [1 ]
Cook, Sadie [1 ]
Vettese, Emily [1 ]
Soman, Dilip [2 ]
Kuczynski, Susan [3 ]
Schechter, Tal [4 ]
Dupuis, L. Lee [1 ,5 ,6 ]
Sung, Lillian [1 ,4 ]
机构
[1] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Child Hlth Evaluat Sci, 686 Bay St, Toronto, ON M5G 0A4, Canada
[2] Univ Toronto, Rotman Sch Management, 105 St George St, Toronto, ON M5S 3E6, Canada
[3] Ontario Parents Advocating Children Canc OPACC, 99 Citat Dr, Toronto, ON M2K 1S9, Canada
[4] Hosp Sick Children, Div Haematol Oncol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
[5] Univ Toronto, Hosp Sick Children, Dept Pharm, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
[6] Univ Toronto, Hosp Sick Children, Leslie Dan Fac Pharm, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
关键词
Symptom screening; Quality of life; Pediatric; Oncology; REPORTED OUTCOMES; RECEIVING END; CARE; PERCEPTIONS; CHILDREN; CHEMOTHERAPY; RELIABILITY; VALIDITY; ONCOLOGY;
D O I
10.1186/s12885-022-10400-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Primary objective was to determine the feasibility of three times weekly symptom reporting by pediatric cancer patients for eight weeks.Methods: We included English-speaking patients 8-18 years of age with cancer. Patients were sent reminders by text or email to complete Symptom Screening in Pediatrics Tool (SSPedi) three times weekly for eight weeks. When patients reported at least one severely bothersome symptom, the symptom report was emailed to the primary healthcare team. Patient-reported outcomes were obtained at baseline, week 4 +/- 1 and week 8 +/- 1. Symptom documentation, intervention provision for symptoms and unplanned healthcare encounters were determined by chart review at weeks 4 and 8. The primary endpoint was feasibility, defined as at least 75% patients achieving adherence with at least 60% of SSPedi evaluations. We planned to enroll successive cohorts until this threshold was met.Results: Two cohorts consisting of 30 patients (cohort 1 (n = 20) and cohort 2 (n = 10)) were required to meet the feasibility threshold. In cohort 1, 11/20 (55%) met the SSPedi completion threshold. Interventions applied after cohort 1 included engaging parents to facilitate pediatric patient self-report, offering mechanisms to remember username and password and highlighting potential benefits of symptom feedback to clinicians. In cohort 2, 9/10 (90%) met the SSPedi completion threshold and thus feasibility was met. Patient-reported outcomes and chart review outcomes were obtained for all participants in cohort 2.Conclusions: Three times weekly symptom reporting by pediatric patients with cancer for eight weeks was feasible. Mechanisms to enhance three times weekly symptom reporting were identified and implemented. Future studies of longitudinal symptom screening can now be planned.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Feasibility of three times weekly symptom screening in pediatric cancer patients
    Maryann Calligan
    Lauren Chakkalackal
    Grace Dadzie
    Cassandra Tardif-Theriault
    Sadie Cook
    Emily Vettese
    Dilip Soman
    Susan Kuczynski
    Tal Schechter
    L. Lee Dupuis
    Lillian Sung
    [J]. BMC Cancer, 23
  • [2] FEASIBILITY OF THREE TIMES WEEKLY SYMPTOM SCREENING IN PEDIATRIC CANCER PATIENTS
    Calligan, Maryann
    Chakkalackal, Lauren
    Dadzie, Grace
    Tardif-Theriault, Cassandra
    Cook, Sadie
    Vettese, Emily
    Soman, Dilip
    Kuczynski, Susan
    Schechter, Tal
    Dupuis, Lee
    Sung, Lillian
    [J]. PEDIATRIC BLOOD & CANCER, 2022, 69 : S340 - S341
  • [3] A review of symptom screening tools in pediatric cancer patients
    O'Sullivan, Cathy
    Dupuis, L. Lee
    Sung, Lillian
    [J]. CURRENT OPINION IN ONCOLOGY, 2015, 27 (04) : 285 - 290
  • [4] Screening for psychosocial distress in pediatric cancer patients: An examination of feasibility in a single institution
    Schulte, Fiona
    Russell, K. Brooke
    Pelletier, Wendy
    Scott-Lane, Laura
    Guilcher, Gregory M. T.
    Strother, Douglas
    Dewey, Deborah
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2019, 36 (03) : 125 - 137
  • [5] Validation of co-Symptom Screening in Pediatrics Tool: anovel dyadic approach to symptom screening in pediatric patients receiving cancer treatment
    Tomlinson, Deborah
    Dupuis, L. Lee
    Dix, David
    Crellin-Parsons, Nicole
    Cook, Sadie
    Kulkarni, Ketan
    Schechter, Tal
    Tomlinson, George A.
    Sung, Lillian
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (01) : 160 - 166
  • [6] Feasibility of neurobehavioral screening following diagnosis of pediatric cancer
    Pejnovic, Laura P.
    De Luca, Cinzia R.
    Gentle, Ellen
    Anson, Katie
    Ashley, David M.
    Anderson, Vicki A.
    McCarthy, Maria C.
    [J]. PEDIATRIC BLOOD & CANCER, 2012, 59 (02) : 295 - 300
  • [7] Symptom triggered screening for ovarian cancer: A pilot study of feasibility and acceptability
    Goff, Barbara A.
    Lowe, Kimberly A.
    Kane, Jeannette C.
    Robertson, Marissa D.
    Gaul, Marcia A.
    Andersen, M. Robyn
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 124 (02) : 230 - 235
  • [8] The Pediatric Symptom Checklist: Comparison of symptom profiles using three factor structures between pediatric gastroenterology and general pediatric patients
    Gutierrez-Colina, Ana M.
    Lee, Jennifer L.
    Reed-Knight, Bonney
    Hayutin, Lisa
    Lewis, Jeffery D.
    Blount, Ronald L.
    [J]. CHILDRENS HEALTH CARE, 2017, 46 (04) : 315 - 330
  • [9] Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly
    Wing Cheung
    Neil Minton
    Kulasiri Gunawardena
    [J]. European Journal of Clinical Pharmacology, 2001, 57 : 411 - 418
  • [10] Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly
    Cheung, W
    Minton, N
    Gunawardena, K
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (05) : 411 - 418